Summary
Tom Wiggins is a molecular microbiologist with a Ph.D. in biotechnology and nine years of infectious disease research experience focused on drug discovery against Mycobacterium tuberculosis. Currently an Open Lab Fellow at GSK and a postdoctoral researcher at Albert Einstein College of Medicine, he leads projects combining protein engineering, metabolomics, bioenergetics, and in vitro/in vivo drug screening to identify novel antibiotic strategies and synergistic regimens. He brings extensive hands-on expertise in DNA cloning, protein purification, assay development, and translational drug testing, with a track record of collaborative, multidisciplinary projects. Tom’s work uniquely bridges fundamental bioenergetics with applied therapeutic development, aiming to translate metabolic insights into more effective TB treatments. Based in New York, he is seeking roles in the pharmaceutical or biotech industry where his combination of bench skill and translational focus can accelerate infectious disease drug development.
9 years of coding experience
Doctor of Philosophy - PhD, Biotechnology, Doctor of Philosophy - PhD, Biotechnology at University of Otago